Germline TP53 mutations result in the classical Li-Fraumeni or Li-Fraumeni-like syndromes (LFS/LFL) [1], rare inherited syndromes with a lifetime cancer penetrance up to 73% for males and ∼100% for females[2]–[7]. The gene discussed is TP53; the disease is Li-fraumeni-like syndrome.